Modulation of macrophage phenotype to treat liver fibrosis-Current approaches and future possibilities.

Abstract excerpt

Liver fibrosis is a leading cause of death worldwide, accounting for approximately 2 million deaths annually. Despite its wide prevalence, there are currently no pharmacological therapies that directly reverse the fibrotic process in patients. Studies over the last decade have revealed that liver fibrosis is reversible in patients and in animal models. Further, studies aimed at elucidating the mechanism of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Fibrosis
• Share to Hepatic Stellate Cells
• Share to Liver